Latest eBooks

In this eBook, we highlight developments in cancer research through a selection of articles, interviews and graphics.

The development of -omics technologies marked a significant step away from the study of a few hundred proteins, genes and metabolites into a field where scientists can examine populations of these molecules, over thousands of molecules in an unbiased manner.

For this, we need to look at the ultimate output of the genome: the proteome. After many years in the shadow of genomics, proteomics is now ready to step into the spotlight.

Lipid nanoparticles (LNPs) are effective non-viral vectors, which are widely used delivery vehicles for genetic medicines. It is therefore important to understand and limit LNP-related impurities to help ensure genetic product integrity and mitigate risks to patient safety and product efficacy.

Oligonucleotide therapeutics are short DNA or RNA molecules that modulate the expression of target RNA for the treatment of diseases. The success of mRNA-based COVID-19 vaccines has brought renewed interest to other nucleic acid drugs, and the oligo therapeutics market is expected to grow by 25–30% in the next five years with over 1,000 oligonucleotide molecules currently in the pipeline.

Download this eBook to learn more about what’s next for mRNA vaccines,
scaling up in vitro transcription for mRNA production, tools for mRNA analysis
plus the future of mRNA technology.

Download this eBook to learn how to choose the right biomolecular imager for your lab, achieve high-quality, high sensitivity gel images as well as select the best imaging equipment for your research.

Download this eBook to explore recent advances in proteomics technologies, key applications including vaccine design and drug development, and the problem of understudied proteins.

Immunotherapy using immune checkpoint inhibitors (ICI) has revolutionized the treatment landscape in oncology, but significant challenges remain. Without reliable tools to identify likely responders, patients who may have responded are not prescribed ICIs.

Download this eBook to explore how these new technologies have enabled some of the most recent discoveries in areas such as molecular mechanisms of cancer, cancer biomarkers as well as vaccines and therapeutics to tackle cancer.